Showing results (1-10 of 221) with videos related to
Sort By:
Pageof 23
The American Journal of the Medical Sciences|September 1, 1993
Molecular basis of Charcot-Marie-Tooth disease type 1A: gene dosage as a novel mechanism for a common autosomal dominant conditionB B Roa, J R LupskiHuman Mutation|January 1, 1996
Myelin protein zero (MPZ) gene mutations in nonduplication type 1 Charcot-Marie-Tooth diseaseB B Roa, L E Warner, C A Garcia, et al.International Journal of Neurology|January 1, 1991
Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathyB B Roa, C A Garcia, J R LupskiAnnual Review of Medicine|March 12, 1999
Hereditary peripheral neuropathies: clinical forms, genetics, and molecular mechanismsL E Warner, C A Garcia, J R LupskiHuman Molecular Genetics|June 17, 1999
Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathiesL E Warner, J Svaren, J Milbrandt, et al.Human Mutation|January 1, 1997
Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine-Sottas caseL E Warner, M Shohat, Z Shorer, et al.Pediatric Neurology|April 20, 1999
Congenital hypomyelinating neuropathy: two patients with long-term follow-upJ P Phillips, L E Warner, J R Lupski, et al.Nature Genetics|November 1, 1993
Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22 (PMP22) geneB B Roa, P J Dyck, H G Marks, et al.Annals of the New York Academy of Sciences|November 1, 2017
Molecular Mechanisms for CMT1A Duplication and HNPP DeletionC F Boerkoel, K Inoue, L T Reiter, et al.Annals of the New York Academy of Sciences|December 10, 1999
Molecular mechanisms for CMT1A duplication and HNPP deletionC F Boerkoel, K Inoue, L T Reiter, et al.Pageof 23